Le Lézard
Classified in: Health
Subject: SVY

Global Allergy Immunotherapies Markets, 2018-2019 & 2024: Demand for Sophisticated and Long-Term Treatment Options is Increasing

DUBLIN, Aug. 23, 2019 /PRNewswire/ -- The "Allergy Immunotherapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global allergy immunotherapies market was worth US$ 1.6 Billion in 2018

Allergy immunotherapy, also known as desensitization or hypo-sensitization, is a preventive medical treatment for allergic reactions to allergens including various foods, drugs, bee venom, grass pollens and house dust mites. It alters the immune system's response by gradually increasing the doses of the allergen.

Before the treatment begins, an allergist and patient analyze triggering factors for allergy symptoms, which may involve skin and blood tests to confirm the allergens. Allergy immunotherapy helps in reducing inflammation, offering long-term impact, increasing immunological tolerance, changing the course of the disease and improving the quality of the patient's life.

In recent years, there has been a rise in the prevalence of allergies around the world on account of various environmental and lifestyle factors that influence the functioning of the immune system. With the growing awareness of allergy immunotherapies, elevating income levels and increasing healthcare expenditure, the demand for sophisticated and long-term treatment options is increasing, which in turn is stimulating the growth of the market. It is further supported by the rising clinical research and development budget owing to several initiatives undertaken by both governmental and non-governmental organizations around the world.

Further, with the latest drug development technologies, pharmaceutical firms have created more efficient immunotherapies for treating an array of allergies successfully. This, coupled with advancements in the field of allergy diagnostics, is catalyzing the global allergy immunotherapies market growth.

Looking forward, the market to reach a value of US$ 2.4 Billion by 2024, registering a CAGR of around 7% during 2019-2024.

Key Questions Answered in This Report:

Key Topics Covered:

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.4 Market Estimation
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Allergy Immunotherapies Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by Treatment Type
5.4 Market Breakup by Allergy Type
5.5 Market Breakup by Distribution Channel
5.6 Market Breakup by Region
5.7 Market Forecast

6 Market Breakup by Treatment Type
6.1 Subcutaneous Immunotherapy (SCIT)
6.2 Sublingual Immunotherapy (SLIT)

7 Market Breakup by Allergy Type
7.1 Allergic Rhinitis
7.2 Asthma
7.3 Food Allergy
7.4 Venom Allergy
7.5 Others

8 Market Breakup by Distribution Channel
8.1 Hospital Pharmacy
8.2 Retail Pharmacy
8.3 Online Pharmacy

9 Market Breakup by Region

10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis
13.1 Price Indicators
13.2 Price Structure
13.3 Margin Analysis

14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 ALK-Abello A/S
14.3.2 Allergy Therapeutics
14.3.3 Stallergenes Greer
14.3.4 HAL Allergy Group
14.3.5 DBV Technologies
14.3.6 Merck Group
14.3.7 Aimmune Therapeutics
14.3.8 Circassia Pharmaceuticals
14.3.9 Anergis SA
14.3.10 Biomay AG

For more information about this report visit https://www.researchandmarkets.com/r/oqvzeb

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

These press releases may also interest you

at 03:00
What can be said of people who would rather be feared than be loved? Perhaps they get a thrill out of making others feel weak and inferior, or think that having others cower is the fastest way to power. However, if history has taught the world...

at 03:00
NJ Top Docs has reviewed and approved Lisa Silbret, MD and Alan Schechter, MD for 2019. These board certified dermatologists practice in Manalapan, New Jersey which is located in Monmouth County. At Dr. Silbret and Dr. Schechter's office, they...

at 03:00
Dr. Perry Patel, an Arroyo Grande dentist, recently announced that he has been certified by the American Academy of Facial Esthetics (AAFE) to administer dermal filler injections. Dr. Patel offers Juvederm® dermal fillers and SkinMedica® professional...

at 02:00
Chronic kidney disease affects 1 out of 10 people worldwide and is steadily increasing. When it reaches end-stage renal disease and endangers the lives of patients, dialysis or transplantation is required. Renal transplantation is the treatment of...

20 sep 2019
SymbioCellTech, LLC , a biotechnology company in Salt Lake City pioneering stem cell therapy for diabetes and associated auto-immune disorders and microvascular conditions, today announced the online journal PLOS ONE published interim data...

20 sep 2019
Dr. Jason Emer of Emerage Medical is globally recognized as one of the most cutting-edge, board-certified dermatologist and cosmetic surgeons in the field of advanced dermatology, plastic surgery and body contouring. Continuing his passion and...

News published on 23 august 2019 at 11:00 and distributed by: